Free Trial
→ A new rule goes live in July — and the banks are quietly cashing in (From American Alternative) (Ad) Buy RCKTW Stock  Free RCKTW Stock Alerts

Rocket Pharmaceuticals (RCKTW) SEC Filings & 10K Form

Rocket Pharmaceuticals logo
$0.04 -0.01 (-14.99%)
As of 06/18/2025 02:07 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Rocket Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
06/18/2025
3:52 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
6:43 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/27/2025
6:40 AM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
2:13 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:15 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:17 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:21 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:29 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:32 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:18 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
8:59 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
9:02 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
04/30/2025
3:14 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form DEF 14A
04/30/2025
3:15 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form DEFA14A
04/30/2025
3:16 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form ARS
04/22/2025
2:17 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/14/2025
5:57 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
4:10 PM		MAVERICK CAPITAL LTD (Filed by)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form SCHEDULE 13G
04/10/2025
3:07 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
2:26 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2025
3:06 PM		Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:24 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
2:25 PM		Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:01 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Schwartz Jonathan David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:01 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
11:56 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:29 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:09 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:25 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/05/2025
6:47 PM		Pratumsuwan Piratip (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:43 PM		Pratumsuwan Piratip (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2025
2:15 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
8:28 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
2:33 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:38 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
RTW INVESTMENTS, LP (Reporting)
WONG RODERICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:51 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13D/A
12/12/2024
5:02 AM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 424B5
11/25/2024
3:05 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Top Picks for Trump’s Pro-Crypto America (Ad)

The crypto summit that could change your life Right now, fear is rampant – creating the perfect buying opportunity when you discover which coins 27 crypto experts are personally accumulating At the Crypto Community Summit, these top industry leaders will reveal exactly which altcoins they believe will explode when this temporary dip ends.

Secure your spot before registration closes
11/25/2024
3:05 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:26 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:06 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:58 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:27 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
3:15 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
9:52 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:45 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
2:24 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:34 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
4:05 PM		Bjork Elisabeth (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:07 PM		Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:05 PM		Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
3:06 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:26 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
2:29 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:39 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:16 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:23 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:15 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
3:05 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:22 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:05 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
White Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
2:17 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RCKTW) was last updated on 6/20/2025 by MarketBeat.com Staff
From Our Partners
379 passengers walked away from this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Why Is President Trump Fast-Tracking These Companies?
Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...
InvestorPlace | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Most Bitcoin holders have no idea this exists
Here’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...
Brownstone Research | Sponsored
War-Proof Power
Why This "Weird" Government Land Auction Was No Ordinary Sale When 218,000 acres of land... smack in the m...
Stansberry Research | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Trump’s true trade war strategy
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...
Porter & Company | Sponsored